Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Upgrades FibroGen to Outperform

William Blair Upgrades FibroGen to Outperform

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

January 31, 2023

1 minute read

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs

April 25, 10:02 AM

Biogen Inc (NASDAQ:BIIB) posted Q1 FY23 sales of $2.46 billion, beating the consensus of $2.34 billion, down 3% Y/Y and flat%…

April 24, 1:00 PM

Deutsche Bank has decided to maintain its Buy rating of Autoliv (NYSE:ALV) and lower its price target from…

April 5, 10:58 AM

Walt Disney CEO Bob Iger revealed that the Mouse House will start Disney Plus password sharing crackdown from June.

October 2, 5:21 AM

The CNN Money Fear and Greed index remained in the "Fear" zone on Friday.